VENOUS THROMBOEMBOLISM IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: INSIGHTS FROM REAL-WORLD DATA

EHA Library, Vladimir Otasevic, 4159396

TARGETED SUPPRESSION OF EFFECTOR T CELLS BY GPIBα CAAR-TREG CELLS IN REFRACTORY/RELAPSED IMMUNE THROMBOCYTOPENIA

EHA Library, Jinhui Shu, 4159395

MICROFLUIDIC TESTING USING THE MAASTRICHT FLOWCHAMBER IN PATIENTS WITH BLEEDING DISORDER OF UNKNOWN CAUSE (BDUC)

EHA Library, Amaury Monard, 4159394

HEPATIC PLASMINOGEN LOWERING WITH RNA INTERFERENCE FOR THE TREATMENT OF BLEEDING DISORDERS IS UNLIKELY TO POSE THROMBOTIC RISK BASED ON UK BIOBANK ANALYSES AND MOUSE MODELS OF PROVOKED THROMBOSIS

EHA Library, Rodney Camire, 4159393

BLASTS- AND MODIFIED EASIX-GUIDED RISK STRATIFICATION FOR CAR-T-ASSOCIATED COAGULOPATHY AND OUTCOMES

EHA Library, Yingying Li, 4159392

SAFETY OF HYPOXIC RED BLOOD CELL ADMINISTRATION IN PATIENTS WITH TRANSFUSION-DEPENDENT HEMATOLOGICAL MALIGNANCIES

EHA Library, Håkon Reikvam, 4159386

BLOOD GROUP GENOTYPE DIVERSITY IN SICKLE CELL DISEASE PATIENTS: ANTIGENIC PROFILE FROM A SINGLE CENTER AND SYSTEMATIC REVIEW OF THE LITERATURE

EHA Library, Luiza Francisco Trafane, 4159385

CORD RED BLOOD CELL TRANSFUSIONS IN EXTREMELY LOW GESTATIONAL AGE NEONATES TO PREVENT SEVERE ROP: RESULTS OF THE RANDOMIZED CLINICAL TRIAL BORN

EHA Library, Claudio Pellegrino, 4159384

TARGETING THE MTOR PATHWAY TO REGULATE PIEZO1-MEDIATED IRON OVERLOAD

EHA Library, Federica Maria Esposito, 4159383

IRON TRAPPING IN MACROPHAGES RESHAPES THE HOMEOSTASIS OF THE HAEMATOPOIETIC SYSTEM

EHA Library, Laura Crisafulli, 4159382

INVASIVE FUNGAL INFECTIONS IN ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY RESULTS OF A MULTICENTRIC PROSPECTIVE SEIFEM STUDY (ALL-IFI)

EHA Library, Chiara Cattaneo, 4159381

INCIDENCE AND RISK FACTORS FOR LATE CYTOMEGALOVIRUS (CMV) BLOOD INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (ALLOHCT)

EHA Library, George Chen, 4159380

CHANGES IN THE SPECTRUM AND PROGNOSIS OF INVASIVE FUNGAL DISEASES IN CZECH, SLOVAK, AND CROATIAN HEMATOLOGY CENTERS FROM 2000 TO 2023 - FIND ANALYSIS

EHA Library, Barbora Weinbergerová, 4159379

LONG TERM FOLLOW UP OF THE BATMO PROTOCOL (BEST-ANTIMICROBIAL-THERAPY-TMO) AND COMPARISON WITH HYSTORICAL DATA

EHA Library, Michele Malagola, 4159378

REAL-WORLD INSIGHT ON TREATMENT WITH MARIBAVIR FOR CLINICALLY-SIGNIFICANT CMV INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: A RETROSPECTIVE INTERNATIONAL IDWP EBMT STUDY

EHA Library, Annalisa Paviglianiti, 4159377

G-CSF IMPROVES TREG SELECTION AND OUTCOMES OF HLA-HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION WITH T CELL ADOPTIVE IMMUNOTHERAPY

EHA Library, Rebecca Sembenico, 4159341

PHARMACOKINETIC-GUIDED ATG DOSING OPTIMIZES OUTCOMES IN MYELOABLATIVE HAPLO-CORD HCT

EHA Library, Qingya cui, 4159340

ANTI-CD25 ANTIBODY AS AN ALTERNATIVE TO METHOTREXATE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS RESULTED IN BETTER OUTCOMES IN PATIENT OF CHIMERIC ANTIGEN RECEPTOR-T CELL THERAPY BRIDGING TO TRANSPLANT

EHA Library, Zhihui Li, 4159339

AUTONOMOUS AI-DRIVEN INTENSIFIED PROPHYLAXIS OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE IN HAPLOIDENTICAL TRANSPLANTS: A SINGLE-CENTRE, PROOF-OF-CONCEPT, PHASE 2 TRIAL

EHA Library, Yigeng Cao, 4159338

CARFILZOMIB INDUCTION, CONSOLIDATION, AND MAINTENANCE WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANT: LONG-TERM FOLLOW-UP OF THE RANDOMISED, PHASE 2 FORTE TRIAL

EHA Library, Francesca Gay, 4159271

HEMATOLOGICAL IMPROVEMENT AND OTHER CLINICAL BENEFITS OF ELRITERCEPT AS MONOTHERAPY AND IN COMBINATION WITH RUXOLITINIB IN PARTICIPANTS WITH MYELOFIBROSIS (MF) FROM THE ONGOING PHASE 2 RESTORE TRIAL

EHA Library, Timothy Devos, 4159297

PRELIMINARY DATA FROM PHASE I/II STUDY OF NUVISERTIB, AN ORAL INVESTIGATIONAL SELECTIVE PIM1 INHIBITOR, SHOWED CLINICAL RESPONSE CORRELATING WITH CYTOKINE MODULATION IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Lindsay Rein, 4159298

ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-RISK MYELOFIBROSIS

EHA Library, Harry Gill, 4159299

PELABRESIB IN COMBINATION WITH RUXOLITINIB FOR JANUS KINASE INHIBITOR-NAIVE PATIENTS WITH MYELOFIBROSIS: 72-WEEK FOLLOW-UP WITH LONG-TERM EFFICACY OUTCOMES OF THE PHASE III MANIFEST-2 STUDY

EHA Library, Alessandro Vannucchi, 4159300

SANRECO, AN ON-GOING PHASE1/2 STUDY EVALUATING DIVESIRAN, A NOVEL GALNAC-CONJUGATED SIRNA, IN PATIENTS WITH POLYCYTHEMIA VERA

EHA Library, Marina Kremyanskaya, 4159301

ACIMTAMIG (AFM13) IN COMBINATION WITH ALLONK® (AB-101) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: RESULTS FROM THE DOSE FINDING PHASE OF THE LUMINICE-203 PHASE 2 STUDY

EHA Library, Joseph Maakaron, 4159302

LONG-TERM RESPONSES AND LATE TOXICITIES IN ADVANCED-STAGE HODGKIN LYMPHOMA: A 10-YEAR UPDATE OF THE HD0607 TRIAL

EHA Library, Alessandro Cellini, 4159303

BRECADD: THE OPTIMAL TREATMENT FOR ADVANCED-STAGE HODGKIN LYMPHOMA — A METANALYSIS AND AN INDIRECT COMPARISON WITH INDIVIDUAL PATIENT DATA EXTRACTION

EHA Library, Andrea Visentin, 4159304

THE ROLE OF STEM CELL TRANSPLANTATION AS CONSOLIDATION THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH CHECKPOINT INHIBITORS: ITALIAN MULTICENTER EXPERIENCE

EHA Library, Elisa Lucchini, 4159305

ELEVATED SERUM TARC AFTER ONE CYCLE OF BV-AVD CORRELATES WITH ADVERSE PROGNOSIS DESPITE ESCALATION TO BRECADD IN ADVANCED STAGE HODGKIN LYMPHOMA: BIOMARKER ANALYSIS FROM THE EORTC-1537-COBRA TRIAL

EHA Library, Sophie Teesink, 4159306

PROSPECTIVE VALIDATION OF END OF TREATMENT CTDNA-MRD BY PHASED-SEQ IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL

EHA Library, Martine Chamuleau, 4159317

FRAIL IS NOT FAIL: COMORBIDITIES DO NOT AFFECT NON-RELAPSE MORTALITY AND SAFETY IN PATIENTS WITH LBCL TREATED WITH CAR-T THERAPY

EHA Library, Eugenio Galli, 4159318

THERAPEUTIC OUTCOMES IN T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL): A COLLABORATIVE MULTI-CENTER STUDY COHORT AND GENOMIC ANALYSIS

EHA Library, Jonathan Brammer, 4159319

OUTCOMES IN AN INTERNATIONAL MULTICENTRE STUDY OF 600 PATIENTS WITH CNS RELAPSE OF LARGE B CELL LYMPHOMA: COMPARTMENT OF RELAPSE IS PROGNOSTIC

EHA Library, Diva Baggio, 4159320

PERIPHERAL T-CELL LYMPHOMAS IN THE ELDERLY: REPORT ON 922 PATIENTS FROM THE T-CELL PROJECT 1.0 AND 2.0.

EHA Library, Tetiana Skrypets, 4159321

SINGLE CELL ANALYSIS REVEALS EXTENSIVE IMMUNE EXHAUSTION AND MEMORY-CELL LIKE ORIGIN IN FOLLICULAR LYMPHOMA WITH INCREASED IRF4 EXPRESSION

EHA Library, Patrizia Mondello, 4159327

MULTI-OMICS DISSECTION OF EBV-DRIVEN HETEROGENEITY, METABOLIC REMODELING, AND TUMOR CELLULAR LANDSCAPE IN ENKTL PROGRESSION

EHA Library, Jinhua Liang, 4159328

PTPN2 INHIBITION DISRUPTS MITOCHONDRIAL RENEWAL AND BLOCKS TFRC-MEDIATED PINK1-PRKN-DEPENDENT MITOPHAGY TO EXERT ANTI-TUMOR ACTIVITIES IN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA.

EHA Library, Jinhua Liang, 4159329

REPRESSION OF MIR-29 VIA MYC LEADS TO INCREASED CD40 SIGNALING IN TRANSFORMED FOLLICULAR LYMPHOMA (FL) AND UNFAVOURABLE PROGNOSIS IN FL

EHA Library, Daniel Filip, 4159330

TITLE: TRANSCRIPTIONAL AND PROTEOMIC LANDSCAPE OF EBV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA: GENOMIC AND VIRAL FACTORS DRIVING AN IMMUNOTOLERANT NICHE

EHA Library, Axel Künstner, 4159331

JAK/ROCK INHIBITION WITH ROVADICITINIB SUPPRESSES MURINE AND HUMAN ACUTE GRAFT-VERSUS-HOST DISEASE: THE RESULTS OF PRECLINICAL AND PHASE 1B STUDY

EHA Library, Yanmin Zhao, 4159332

TARGETED DOSING OF ANTI-THYMOCYTE GLOBULIN VERSUS FIXED DOSING STRATEGY IN PATIENTS UNDERGOING UNMANIPULATED HAPLOIDENTICAL HAEMATOPOIETIC STEM-CELL TRANSPLANTATION: A RANDOMIZED, MULTICENTER, PHASE 3 CLINICAL TRIAL

EHA Library, Dai-Hong Liu, 4159333

THE RANDOMIZED CONTROLLED HAMLET TRIAL SHOWS NO SURVIVAL DIFFERENCE BETWEEN HAPLOIDENTICAL RELATED AND SINGLE HLA-LOCI MISMATCHED UNRELATED DONOR TRANSPLANTATION IN PATIENTS WITH HIGH RISK AML/ALL/MDS

EHA Library, Johannes Schetelig, 4159334

WHO IS THE BEST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT DONOR FOR SEVERE APLASTIC ANEMIA? A MULTICENTER RETROSPECTIVE EXPERIENCE FROM CHINA.

EHA Library, Xiao-Di Ma, 4159335

COMPARABLE SURVIVAL OUTCOMES IN HLA-MATCHED AND HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA PATIENTS AGED 40-50: A CBMTR REGISTRY-BASED PSM ANALYSIS OVER THE LAST DECADE

EHA Library, Lan-Ping Xu, 4159336

CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (KRD) AS MAINTENANCE THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Dominik Dytfeld, 4159270

LONG-TERM (≥5 YEAR) REMISSION AND SURVIVAL AFTER TREATMENT WITH CILTACABTAGENE AUTOLEUCEL IN CARTITUDE-1 PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Sundar Jagannath, 4159269

THE TRIPLE COMBINATION OF VENETOCLAX-IBRUTINIB-OBINUTUZUMAB PROLONGS PROGRESSION-FREE SURVIVAL COMPARED TO VENETOCLAX-CD20-ANTIBODY COMBINATIONS AND CHEMOIMMUNOTHERAPY IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: FINAL ANALYSIS FROM THE PHASE 3 GAIA/CLL13 TRIAL

EHA Library, Moritz Fürstenau, 4159268

CYCLOPHOSPHAMIDE IS SUPERIOR TO METHOTREXATE IN PREVIOUSLY UNTREATED LARGE GRANULAR LYMPHOCYTE LEUKEMIA. FINAL RESULTS OF A PROSPECTIVE, MULTICENTRIC, PHASE II RANDOMIZED CONTROLLED TRIAL CT01976182.

EHA Library, Thierry Lamy, 4159267

DISCOVERY OF ATP2B1+ CD49F+ HUMAN HEMATOPOIETIC STEM CELLS WITH SUPERIOR LONG-TERM MULTILINEAGE RECONSTITUTION

EHA Library, Angelica Varesi, 4159347

THE B-ALL STROMAL LANDSCAPE: SPATIAL ORGANIZATION AND FUNCTIONAL SPECIALIZATION OF DISTINCT NICHE SUBTYPES

EHA Library, Mauricio Ferrao Blanco, 4159348

ENHANCE THE THERAPEUTIC EFFICACY OF HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS IN PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE THROUGH CRISPLD2 MODULATION

EHA Library, Xu Qing, 4159349

TGF-ß1-TRIGGERED MALADAPTIVE BONE MARROW ENDOTHELIUM IMPEDES HEMATOPOIETIC RECOVERY

EHA Library, Zhong-Shi Lyu, 4159350

RANKL CYTOKINE IS A NOVEL SUPPORTIVE SIGNAL IN THE BONE MARROW HEMATOPOIETIC NICHE

EHA Library, Francesca Ficara, 4159351

EPITOPE EDITING ENABLES IMMUNE-BASED SELECTION OF MULTIPLEX GENOME ENGINEERED STEM CELLS AND IMPROVED NON-GENOTOXIC CONDITIONING

EHA Library, Gabriele Casirati, 4159352

A FUNCTIONAL CAR-T CELL ATLAS TO UNRAVEL REGULATORY MECHANISMS OF CAR-T CELLS

EHA Library, Juan Rodriguez-Madoz, 4159353

TYPE I INTERFERON IMPAIRS CAR-T CELL FUNCTION BY DISRUPTING IMMUNE SYNAPSE ASSEMBLY

EHA Library, Meijuan Huang, 4159354

PRECLINICAL DEVELOPMENT OF CCR4 CAR T CELLS FOR THE TREATMENT OF T-NHL

EHA Library, Marissa Del Real, 4159355

IPSC-DERIVED CD2-TARGETED CHIMERIC ANTIGEN RECEPTOR-T CELL THERAPY FOR T CELL MALIGNANCIES

EHA Library, Shintaro Kinoshita, 4159356

NMNAT3 DEFICIENCY: A NOVEL RED BLOOD CELL ENZYMOPATHY

EHA Library, Titine Ruiter, 4159372

EFFICACY AND SAFETY OF MITAPIVAT IN PEDIATRIC PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED: RESULTS FROM THE PHASE 3 RANDOMIZED GLOBAL PLACEBO-CONTROLLED ACTIVATE-KIDST TRIAL

EHA Library, Rachael F. Grace, 4159373

SATISFY: MITAPIVAT IN ADULTS WITH ERYTHROCYTE MEMBRANOPATHIES AND CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II: A EUROBLOODNET, MULTICENTER, SINGLE-ARM, PHASE 2 STUDY

EHA Library, Thomas Doeven, 4159374

LONG-TERM EFFICACY AND SAFETY STUDY OF RILZABRUTINIB, ORAL BRUTON TYROSINE KINASE INHIBITOR, IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): LUMINA PHASE 2B PART B

EHA Library, Bruno Fattizzo, 4159375

THREE-YEAR SAFETY, EFFICACY, AND RENAL OUTCOMES OF MITAPIVAT TREATMENT IN SICKLE CELL DISEASE: RESULTS FROM A PHASE 2, OPEN-LABEL STUDY

EHA Library, Geoffrey Kuppens, 4159376

TARGETING C-MYC MRNA WITH RIBOTAC: A NOVEL STRATEGY FOR MYELOMA TREATMENT IN VITRO AND IN VIVO

EHA Library, Domenico Maisano, 4159266

ENHANCER EXTRACHROMOSOMAL CIRCULAR DNA ANKRD28 DRIVES DRUG RESISTANCE VIA POU2F2-MEDIATED TRANSCRIPTIONAL REWIRING IN MULTIPLE MYELOMA

EHA Library, Binzhen Chen, 4159265

IN MULTIPLE MYELOMA, DEL17P CONFERS VULNERABILITY TO THE INHIBITION OF PKMYT1 KINASE.

EHA Library, Anaïs Schavgoulidze, 4159264

MULTIOMICS CHARACTERIZATION OF MINIMAL RESIDUAL DISEASE (MRD) KINETICS IN MULTIPLE MYELOMA (MM) PATIENTS REVEALS THAT EARLY IMMUNOTHERAPY INTERCEPTION DRIVES CLINICAL BENEFIT IN EXPERIMENTAL MODELS

EHA Library, Noelia Collado-Gisbert, 4159263

INTEGRATIVE MULTIOMIC ANALYSIS OF MULTIPLE MYELOMA IDENTIFIES MOLECULAR PREDICTORS OF MRD IN THE MIDAS TRIAL

EHA Library, Stéphane Minvielle, 4159262

RVU120 ENHANCES ERYTHROID POTENTIAL IN MDS PATIENT-DERIVED CELLS: PRECLINICAL MECHANISTIC INSIGHTS INTO CDK8/CDK19 INHIBITION AND POTENTIAL PATIENT STRATIFICATION

EHA Library, Milena Mazan, 4159251

ACTIVATION OF GENOMIC REGIONS DRIVEN BY PU.1 DISTINGUISHES LOW-RISK MDS SUBSETS CHARACTERIZED BY IMMUNE DYSREGULATION AND PROGRESSION

EHA Library, Veronica Vallelonga, 4159250

DEVELOPMENT OF NOVEL CCL2-DRUG CONJUGATES FOR THE TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKAEMIA

EHA Library, Rachel Cant, 4159249

THE INTERPLAY BETWEEN INFLAMMATION AND IMMUNE ESCAPE IN MDS WITH P53 DYSFUNCTION EVOLUTION: INSIGHTS FROM SINGLE-CELL MULTI-OMICS

EHA Library, Matteo Zampini, 4159248

SINGLE-CELL ATLAS OF PEDIATRIC NRAS-MUTANT MYELOID NEOPLASMS REVEALS MYELOID LINEAGE BIAS AND IDENTIFIES POTENTIAL THERAPEUTIC TARGETS

EHA Library, Suyu Zong, 4159247

TUSCANY STUDY OF SAFETY AND EFFICACY OF TUSPETINIB PLUS STANDARD OF CARE VENETOCLAX AND AZACITIDINE IN STUDY PARTICIPANTS WITH NEWLY DIAGNOSED AML INELIGIBLE FOR INDUCTION CHEMOTHERAPY

EHA Library, Rafael Bejar, 4159216

AZACITIDINE, VENETOCLAX, AND REVUMENIB FOR NEWLY DIAGNOSED OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA (AML) AND NPM1 MUTATION OR KMT2A REARRANGEMENT: UPDATED RESULTS FROM THE BEAT AML CONSORTIUM

EHA Library, Joshua Zeidner, 4159215

RP2D DETERMINATION OF BLEXIMENIB IN COMBINATION WITH VEN+AZA: PHASE 1B STUDY IN ND & R/R AML WITH KMT2A/NPM1 ALTERATIONS

EHA Library, Andrew H. Wei, 4159214

ZIFTOMENIB COMBINED WITH INTENSIVE INDUCTION CHEMOTHERAPY (7+3) IN NEWLY DIAGNOSED NPM1-M OR KMT2A-R ACUTE MYELOID LEUKEMIA (AML): UPDATED PHASE 1A/B RESULTS FROM KOMET-007

EHA Library, Harry Erba, 4159213

ALL-ORAL DECITABINE-CEDAZURIDINE (DEC-C) + VENETOCLAX (VEN) IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) INELIGIBLE FOR INDUCTION CHEMOTHERAPY: PHASE 1/2 CLINICAL TRIAL RESULTS

EHA Library, Gail Roboz, 4159212

SPLANCHNIC VEIN THROMBOSIS IN MYELOPROLIFERATIVE NEOPLASMS: UPDATED ANALYSIS OF ANTICOAGULATION MANAGEMENT AND OUTCOMES IN A GLOBAL ABDOMINAL/SPLANCHNIC VEIN THROMBOSIS RETROSPECTIVE OBSERVATIONAL STUDY IN 889 MPN PATIENTS (GASTRO-MPN)

EHA Library, Mandy Lauw, 4159397

INCIDENCE AND CLINICAL OUTCOMES OF ERYTHROCYTOSIS ASSOCIATED WITH SGLT-2 INHIBITORS: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Ji Yun Lee, 4159398

SPLANCHNIC VEIN THROMBOSIS WITH AND WITHOUT MYELOPROLIFERATIVE NEOPLASMS: A COMPARATIVE COHORT STUDY

EHA Library, Amica Ko, 4159399

A PHENOME-WIDE ASSOCIATION STUDY (PHEWAS) OF ADAMTS13 VARIANTS YIELDS INSIGHT INTO THE EFFECT OF ADAMTS13 MUTATIONS

EHA Library, Matthew Carter, 4159400

THROMBOTIC ADVERSE EVENTS IN PATIENTS RECEIVING THROMBOPOIETIN RECEPTOR AGONISTS: A EUROPEAN MULTICENTER STUDY

EHA Library, Maria Lozano, 4159401

CTA311, A UNIVERSAL (U) ANTI-CD19 CAR-T THERAPY WITH IMPROVED PERSISTENCE FOR PATIENTS (PTS) WITH CD19+ RELAPSED/ REFRACTORY (R/R) ACUTE B-LYMPHOBLASTIC LEUKEMIA (B-ALL)

EHA Library, Xiaoyu Zhu, 4162554

TISAGENLECLEUCEL VERSUS MOSUNETUZUMAB IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: AN UPDATED MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) ANALYSIS AFTER 3-YEAR FOLLOW-UP DATA

EHA Library, Catherine Thieblemont, 4162555

THE ROLE OF CEREBROSPINAL FLUID INTERLEUKIN-6 IN CAR T CELL-ASSOCIATED NEUROTOXICITY

EHA Library, Jing Pan, 4162556

PHASE I STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SWITCHABLE CAR-T CELL THERAPY WITH FY001 AND CART001 IN PATIENTS WITH REFRACTORY CD20-POSITIVE B-CELL NON-HODGKIN LYMPHOMA (EPOC1803)

EHA Library, Junichiro Yuda, 4162557

A RETROSPECTIVE STUDY ON INFECTION-RELATED MORTALITY AFTER OUTPATIENT CAR-T CELL THERAPY

EHA Library, Aminah Tayyab, 4162558

VARNIMCABTAGENE AUTOLEUCEL DEMONSTRATES SIGNIFICANT, SUSTAINED IMPROVEMENTS AS A FIRST-IN-INDIA PATIENT-REPORTED QUALITY OF LIFE OUTCOMES IN RELAPSED / REFRACTORY B-CELL MALIGNANCIES (IMAGINE STUDY)

EHA Library, Sharat Damodar, 4162559

BKV VIREMIA FOLLOWING CD7-CART CELL THERAPY

EHA Library, Jing Pan, 4162560

CAN ONE SCORING SYSTEM FIT ALL? A COMPARATIVE EVALUATION OF CAR-HEMATOTOX, ALL-HT, AND EIPM FOR PREDICTING IMMUNE EFFECTOR CELL-ASSOCIATED HEMATOTOXICITY (ICAHT) AFTER CAR-T IN HEMATOLOGICAL MALIGNANCIES

EHA Library, Ao-ran Zhang, 4162561

AUTOLOGOUS CD19-DIRECTED CAR-T EXHIBIT PROMISING SAFETY AND EFFICACY IN REFRACTORY PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Shiqi Li, 4162562

PTTD BRIDGING REGIMEN FACILITATES LOW-NEUROTOXICITY CAR-T THERAPY IN MULTIPLY RELAPSED CENTRAL NERVOUS SYSTEM LYMPHOMA: A PRELIMINARY EXPLORATORY STUDY

EHA Library, yajing zhang, 4162563

ZANUBRUTINIB COMBINED WITH ANTI-CD19 CAR-T CELL THERAPY IN RELAPSED AND REFRACTORY B-CELL LYMPHOMA

EHA Library, Wei Sang, 4162564

MITIGATING PEAK BUSULFAN TOXICITY BY DOSE TAILORING AND BETTER PREDICTION OF EXPOSURE VARIATIONS UPON DOSE ADJUSTMENTS

EHA Library, Daniele Canarutto, 4162566

COMPARATIVE ANALYSIS OF CD19 CAR T CELL MANUFACTURING AND PHARMACOKINETICS IN SLE AND B-ALL PATIENTS

EHA Library, Jing Pan, 4162567

ALLOGENEIC CD19-TARGETED CAR-T THERAPY FOR REFRACTORY MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

EHA Library, Biao Zheng, 4162568

APPLICATION OF MULTIPARAMETER FCM AND BASELINE IN CD7 CAR-T THERAPY

EHA Library, Hui Wang, 4162569

THIRD PARTY ALLOGENEIC CD4+ T CELL CLONE TARGETING MISMATCHED HLA-DPB1*04:01 TO PREVENT RELAPSE OF HIGH-RISK HEMATOLOGICAL MALIGNANCIES FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT): PHASE I TRIAL INTERIM RESULTS

EHA Library, Béatrice Clémenceau, 4162570